Board of Directors
Ms Alison Coutts is currently the Executive Chairman of Memphasys Ltd and a non-executive director of Lanka Graphite Ltd. She has a Chemical Engineering degree and a Graduate Diploma in Biotechnology from the University of Melbourne and an MBA with distinction from Melbourne Business School.
Ms Coutts has extensive experience across a number of industry sectors and disciplines. This includes international engineering project management with Bechtel Corporation in the UK, USA and New Zealand, strategy consulting with Boston Consulting group, executive search with Egon Zehnder International, investment banking at eG Capital, which she co-founded, technology commercialisation over the past 15 years and executive management, currently with Memphasys Ltd.
She is formerly Chair of CSIRO’s Health Sector Advisory Council and was a co-founder and director of eG Capital, which was a preeminent financial advisory firm in the Australian Life Sciences sector.
She was also the former Chairman of Biolink Associates. Until March 2016 Ms Coutts was a Non-Executive Director of DataDot Ltd .
Whilst at eG Capital (2001-2008) Ms Coutts was responsible for analysing the biotech sector and determining which companies eG Capital would support. She was responsible for a number of IPOs and secondary raisings of client companies, and was the key person promoting eG Capital and its clients to the financial community and to the media.
In 2009, Ms Coutts co-founded Mariposa Healthcare Pty Ltd, a drug development company focussed on COPD with two drugs in phase II development.
In 2010, she co-founded Micro-X Ltd, a company which listed on the ASX in December 2015 for $40 million. Micro-X is producing a novel ultra -small and light X-ray machine using carbon nano tubes.
Mr Goodall is a Non-Executive Director of Memphasys Limited and has served as a Director on the Board since March 2012.
He is also a member of the Company's Audit and Risk and Nomination and Remuneration Committees and has been a respected member of Memphasys' committees since joining the board.
Mr Goodall is the Company's largest shareholder and has been a significant shareholder in Memphasys for many years.
Mr Goodall brings a wealth of business, and commercial experience as well as considered judgement to the his role as a Memphasys' Director.
He is an entrepreneur who has successfully established a number of businesses throughout his career in Australia and New Zealand.
Having had extensive experience in Commercial Property Investment, Mr Goodall is currently involved in the management of his substantial commercial property interests in New Zealand.
Mr Goodall also has a rural property in northern NSW.
Mr Pereira has been admitted to the Supreme Courts of NSW & Victoria and has held a legal practicing certificate for over 20 years.
After an extensive career encompassing funds management, banking and law, Mr Pereira joined Burdett Buckeridge Young Ltd (BBY) where he held positions of Head of Private Advisory and Head of Corporate Finance.
He formed Alchemy Capital Pty Ltd jointly with BBY to promote corporate advisory and capital raising for small/mid cap clients.
After leaving BBY he established Tristar Corporate Advisors Pty Ltd providing corporate advice to a range of private and ASX Listed companies.
Mr Pereira was the Founder and CEO of India Equities Fund Limited which listed on ASX in 2007. He also created Funds Management Pty Ltd to offer a range of investment opportunities in alternative markets.
Mr Pereira has maintained a close interest in his country of birth and is a former President (Victoria) and Deputy Chairman of Australia India Business Council.